Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 990 across all filing types
Latest filing 2025-06-30 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
国浩律师（杭州）事务所关于浙江泰林生物技术股份有限公司2025年第二次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of the 2025 second extraordinary general meeting (EGM) of Zhejiang Tailin Biotechnology Co., Ltd. It details the legal compliance of the meeting's call, attendance qualifications, agenda items, voting procedures, and results. The document does not contain financial statements or management discussion of financial results, nor is it a report publication announcement. It is a legal opinion related to a shareholders' meeting, specifically focusing on the voting results and procedural legality. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (5042 characters) and content confirm it is a full legal opinion on voting results, not just an announcement or notice. Therefore, the correct classification is DVA with high confidence.
2025-06-30 Chinese
2025年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the 2025 second extraordinary shareholders' meeting of Zhejiang Tailin Biotechnology Co., Ltd. It details the meeting date, attendance, voting results on a specific agenda item (the election of an independent director), and includes a legal opinion confirming the validity of the meeting and voting process. The content focuses on the official announcement of voting results from a shareholders' meeting rather than the meeting materials or the full report. The document length is short (1531 characters), and it is clearly an announcement of voting results rather than the full AGM materials or minutes. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-06-30 Chinese
关于全资子公司变更经营范围并完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change in business scope of a wholly-owned subsidiary and the completion of the related industrial and commercial registration. It details the changes in the subsidiary's business license and scope, including specific activities before and after the change. There is no financial data, no mention of financial results, no regulatory certifications, or any other report type content. The document is a formal announcement of a corporate change related to business operations, not a financial report or management information. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-06-26 Chinese
关于变更注册资本并完成工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding a change in registered capital and completion of industrial and commercial registration changes. It includes details about the change in registered capital amount and updated business license information. The document is short (1134 characters) and focuses on a capital change and registration update, not a full financial report or detailed financial data. It is not an annual report, interim report, or earnings release. It is not a report publication announcement since it contains substantive information about the capital change and registration completion. The content fits the category of Share Issue/Capital Change announcements, which cover new share issues or capital changes. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2025-06-23 Chinese
关于签订募集资金四方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a four-party supervision agreement for raised funds related to a convertible bond issuance. It details the management and use of the raised funds, the opening of a special account, and the responsibilities of the involved parties (the company, a subsidiary, a bank, and a sponsor). The document references prior announcements and approvals from regulatory bodies but does not contain financial statements or detailed financial performance data. The length is 3702 characters, which is relatively short and the content is focused on the regulatory and procedural aspects of fund management rather than a financial report or earnings release. Therefore, this document is best classified as a Capital/Financing Update (CAP) because it provides updates on fundraising activities and capital management agreements.
2025-06-23 Chinese
关于控股子公司沃锶达注销完成暨关联交易的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding the completion of the deregistration (cancellation) of its controlling subsidiary and related transaction progress. It includes details about the board meeting approving the deregistration, the receipt of the official deregistration notice, and the impact on consolidated financial statements. The document is short (690 characters) and focuses on a corporate event update rather than financial results or detailed reports. It does not contain financial statements or detailed financial data. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate structure changes and related transactions, not a full report or financial disclosure.
2025-06-19 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.